1Marco M, Michael R. T. The importance of being seizure free: topiramate and psychopathology in epilepsy[J]. Epilepsy Behave, 2003, 4: 430.
2Ana I H, Nuria D O, Jose R G, et al. Two new actions of topiranate:inhibition of depolarizing GABAA-mediated responses and activation of a potassium conductance[J]. Neuropharmacology, 2002, 4: 210.
3Laura S B, Orrin D, John J B, et al. Psychiatric use of ant epileptic treatments. 2002, 3, S54.
4Toufic F, Lindsay M, Donna S, et al. Topiramate overdose: clinical and laboratory features[J]. Epilepsy Behav, 2002, 3: 185.
5Andres M K, Joanne W, Edward F, et al. A past psychiatric history may be a risk factor for TPM-related psychiatric and cognitive adverse events[J]. Epilepsy Behav, 2003, 4: 548.
6Hussain M Z, Chaudhry Z A, Zubaida A, et al. Topiramate in treatment of refractory bipolar depression.J[J]. Affective disorders and antidepressants, 2002, 3: S199.
7Hussein M Z. Treatment of bipolar depression with topiramate[J]. J.Affective disorders and antidepressants, 2002, 3: S222.
8Linda L C, Zelko L, Sarah Y, et al. Do obese depressed patients respond to topiramate a retrospective chart review.J[J]. Affective Disorders, 2002, (69): 251.
9Dolman K S, Chris S. Improvement in depression associated with partial epilepsy in patients treated with aborigine[J]. Epilepsy behav, 2003, 4: 430.
